Atwood & Palmer’s Idexx Laboratories IDXX Stock Holding History

Atwood & Palmer’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$562	–	518
2026 Q1	$562	Buy	+1	New	+$641	﹤0.01%	500

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Atwood & Palmer's IDXX Position: Q2 2026 in Review

Atwood & Palmer sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 1 share — an estimated $562 sold.

Atwood & Palmer first reported a position in IDXX in Q1 2026 and held it in 1 quarter. The position peaked at $562 in Q1 2026. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Atwood & Palmer reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
Atwood & Palmer sold 1 Idexx Laboratories share in Q2 2026, an estimated $562.
Atwood & Palmer first reported a position in Idexx Laboratories in Q1 2026 and held it in 1 quarter.
Atwood & Palmer's Idexx Laboratories position peaked at $562 in Q1 2026.
715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.